Glucient Sr (Metformin Hydrochloride)

Glucient Sr is indicated for the management of type 2 diabetes mellitus as part of a comprehensive treatment strategy.

• As monotherapy in patients whose diet and exercise alone are insufficient to achieve glycemic targets.
• In combination with other oral antidiabetic agents when additional glucose lowering is needed.
• As an adjunct to insulin therapy to reduce the required insulin dose.
• To improve fasting plasma glucose and HbA1c levels in conjunction with lifestyle modifications.

The safety profile of metformin hydrochloride includes both common and less frequent adverse events.

Common

• Gastrointestinal upset such as nausea, abdominal discomfort, or diarrhea.
• Metallic taste in the mouth.
• Mild headache.
• Decreased appetite.

Serious

• Lactic acidosis, a rare but life‑threatening condition.
• Severe skin reactions including Stevens‑Johnson syndrome.
• Hepatotoxicity manifested by jaundice.
• Persistent vomiting leading to dehydration.

Clinicians should evaluate several factors before initiating Glucient Sr to ensure safe use.

• Assess renal function; metformin is contraindicated in severe renal impairment.
• Review hepatic status, as liver disease may increase risk of lactic acidosis.
• Monitor for signs of hypoxia or heart failure, which can predispose to serious metabolic complications.
• Use caution in elderly patients due to altered drug clearance.
• Avoid use in patients with a history of alcohol abuse or acute illness that may affect kidney function.

Metformin hydrochloride may interact with other medicines, affecting its efficacy or safety.

Avoid

• Concurrent use with iodinated contrast agents without appropriate discontinuation.
• Co‑administration with potent inhibitors of renal tubular secretion such as cimetidine.
• Use with other biguanides (e.g., phenformin) due to additive risk of lactic acidosis.

Use with caution

• Combination with insulin or sulfonylureas, which may increase risk of hypoglycemia.
• Concomitant use of corticosteroids or thiazide diuretics that can raise blood glucose levels.
• Administration with alcohol, which may potentiate lactic acidosis.